trial · primary record
bulumtatug fuvedotin
Triple Negative Breast Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 52 |
| Primary completion | 2028-05 |
| Primary endpoint | Objective Response Rate |
| Registry ID | NCT06908928 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:11.283Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06908928
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.